Latest news
A microbial blueprint for climate-smart cows
Recent research has shown that feeding cows red seaweed can dramatically cut the amount of methane that is produced and released into the environment. A new study sheds light on that process and reveals which microbes in the cow’s gut might help reduce methane.
Green chemistry for sustainable personal care
A recent review examined microbial biosurfactants as sustainable alternatives to synthetic surfactants in shampoo formulations. The authors addressed the growing demand for environmentally friendly and dermatologically safe cleansing agents, and emphasized the need to transition from petrochemical-based ingredients such as sodium lauryl sulfate (SLS) to biodegradable biosurfactants.
Vaccine skepticism on social media can predict public health crises
Researchers have developed a new approach that could help public health officials predict where outbreaks might occur. By analyzing social media posts, the method identifies early signs of increasing vaccine skepticism — a warning signal that could emerge before any disease begins to spread.
Micropores pave the way for infection research
Organ-on-a-chip technology often contains gels that imitate the 3D environment of our tissues - however, many of these gels are too dense, hindering the passage of microbes and immune cells, and movement is essential to recreate how infections really develop. In this study, the research team developed a new type of porous gel that solves this problem.
Time to act and not react: how can the European Union turn the tide of antimicrobial resistance?
Despite determined efforts by countries and healthcare professionals, Europe is not on track to meet four of the five AMR targets set by the EU Council for 2030*, according to data released on EAAD.
Apriori Bio and A*STAR Infectious Diseases Labs Announce strategic partnership to advance next generation influenza vaccines
Apriori Bio and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.
A microbial blueprint for climate-smart cows
Recent research has shown that feeding cows red seaweed can dramatically cut the amount of methane that is produced and released into the environment. A new study sheds light on that process and reveals which microbes in the cow’s gut might help reduce methane.
Green chemistry for sustainable personal care
A recent review examined microbial biosurfactants as sustainable alternatives to synthetic surfactants in shampoo formulations. The authors addressed the growing demand for environmentally friendly and dermatologically safe cleansing agents, and emphasized the need to transition from petrochemical-based ingredients such as sodium lauryl sulfate (SLS) to biodegradable biosurfactants.
Vaccine skepticism on social media can predict public health crises
Researchers have developed a new approach that could help public health officials predict where outbreaks might occur. By analyzing social media posts, the method identifies early signs of increasing vaccine skepticism — a warning signal that could emerge before any disease begins to spread.
Apriori Bio and A*STAR Infectious Diseases Labs Announce strategic partnership to advance next generation influenza vaccines
Apriori Bio and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.
Typhoid conjugate vaccine demonstrates strong safety and immunogenicity: Results from Phase 3 study
PATH and EuBiologics Co., LTD have announced Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.®
CARBIOS and Wankai New Materials to build PET biorecycling plant in China
CARBIOS and Wankai New Materials, a subsidiary of Zhink Group, are committed to the large-scale deployment of CARBIOS’ PET biorecycling technology in Asia, with the first step being the construction of a PET biorecycling plant in China.
Micropores pave the way for infection research
Organ-on-a-chip technology often contains gels that imitate the 3D environment of our tissues - however, many of these gels are too dense, hindering the passage of microbes and immune cells, and movement is essential to recreate how infections really develop. In this study, the research team developed a new type of porous gel that solves this problem.
Next-generation microbiome medicine may revolutionize the treatment of Parkinson’s and similar disorders
Scientists have engineered the probiotic bacterium Escherichia coli Nissle 1917 as a drug-delivery system that continuously produces and delivers the gold-standard Parkinson’s drug Levodopa, which is converted to dopamine in the brain. E. coli Nissle strain was chosen for its century-long record of safely treating gastrointestinal disorders in humans.
New blueprint for nature’s carbon-capturing nanomachines revealed
Researchers have uncovered how bacterial organelles assemble, opening new routes for bioengineering and climate innovation. The team has unveiled the most detailed picture yet of how bacteria construct microscopic compartments known as carboxysomes – natural nanomachines that play a vital role in capturing and converting carbon dioxide (CO₂).
Protecting infants against respiratory syncytial virus this winter — ECDC issues advice
ECDC has issued rapid scientific advice for policymakers and public health authorities on ways to mitigate the impact of RSV disease among infants through immunisation and to support intensified efforts to protect them from RSV across Europe.
Biomedical Sciences researcher receives nearly $7 million in federal grants to fight STIs
Cynthia Nau Cornelissen, a Distinguished University Professor and associate director of the Institute for Biomedical Sciences at Georgia State University, has received nearly $7 million in two, five-year federal grants to develop vaccines and therapeutics to combat sexually transmitted infections (STIs).
Korea University College of Medicine’s Vaccine Innovation Center selected as lead institution for 2025 Korea-ARPA-H Health Security Project
The Vaccine Innovation Center at Korea University College of Medicine has been selected as the lead institution for a health security research initiative under the Ministry of Health and Welfare’s “2025 Korea-ARPA-H Project.”